Abstract
The passage of plasma proteins across the placental barrier in humans is known to be highly selective. Thus, free maternal insulin has been reported not to cross the normal maternofetal barrier, although insulin-binding antibodies have been detected in newborn infants whose diabetic mothers received insulin therapy. In this report we demonstrate, with the use of a human antiserum that permits distinction between human and animal insulins, that insulin in the cord blood of each of two neonates of insulin-treated diabetic mothers was, in part, animal insulin. The higher the antibody titer of the mother the greater was the total insulin in the cord plasma and the greater was the fraction that was animal insulin. In case 1 cord plasma insulin was 0.7 unit/liter, of which 10% was animal insulin; in case 2 cord plasma insulin was 3.5 units/liter, of which 25% was animal insulin. The demonstration that antigen restricted from transplacental passage can be transferred while complexed to antibody raises the question whether such fetal exposure would induce partial or total immunologic unresponsiveness subsequently if the fetus were rechallenged with the same antigen.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Adam P. A., Teramo K., Raiha N., Gitlin D., Schwartz R. Human fetal insulin metabolismearly in gestation. Response to acutelevation of the fetal glucose concentration and placental tranfer of human insulin-I-131. Diabetes. 1969 Jun;18(6):409–416. doi: 10.2337/diab.18.6.409. [DOI] [PubMed] [Google Scholar]
- BERSON S. A., YALOW R. S., BAUMAN A., ROTHSCHILD M. A., NEWERLY K. Insulin-I131 metabolism in human subjects: demonstration of insulin binding globulin in the circulation of insulin treated subjects. J Clin Invest. 1956 Feb;35(2):170–190. doi: 10.1172/JCI103262. [DOI] [PMC free article] [PubMed] [Google Scholar]
- BUSE M. G., ROBERTS W. J., BUSE J. The role of the human placenta in the transfer and metabolism of insulin. J Clin Invest. 1962 Jan;41:29–41. doi: 10.1172/JCI104464. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Bauman W. A., Yalow R. S. Differential diagnosis between endogenous and exogenous insulin-induced refractory hypoglycemia in a nondiabetic patient. N Engl J Med. 1980 Jul 24;303(4):198–199. doi: 10.1056/NEJM198007243030406. [DOI] [PubMed] [Google Scholar]
- Goldman J., Baldwin D., Pugh W., Rubenstein A. H. Equilibrium binding assay and kinetic characterization of insulin antibodies. Diabetes. 1978 Jun;27(6):653–660. doi: 10.2337/diab.27.6.653. [DOI] [PubMed] [Google Scholar]
- Isles T. E., Farquhar J. W. The effect of endogenous antibody on insulin-assay in the newborn infants of diabetic mothers. Pediatr Res. 1967 Mar;1(2):110–115. doi: 10.1203/00006450-196703000-00004. [DOI] [PubMed] [Google Scholar]
- Kuzuya H., Blix P. M., Horwitz D. L., Steiner D. F., Rubenstein A. H. Determination of free and total insulin and C-peptide in insulin-treated diabetics. Diabetes. 1977 Jan;26(1):22–29. doi: 10.2337/diab.26.1.22. [DOI] [PubMed] [Google Scholar]
- SPELLACY W. N., GOETZ F. C. Insulin antibodies in pregnancy. Lancet. 1963 Aug 3;2(7301):222–224. doi: 10.1016/s0140-6736(63)90118-1. [DOI] [PubMed] [Google Scholar]